Doctors that prescribe peptides
How does an online visit turn into a legitimate prescription? These articles walk through it: what happens in an intake, why doctors that prescribe peptides online must be licensed in your state, how compounding pharmacies fill orders, and what to expect from your first visit.
If you've only seen peptides sold with no questions asked, this topic explains what the doctor-in-the-loop model changes — including that not everyone qualifies. Every state is different, and the licensure article explains why that matters more than most people expect.
73 articles on this topic
-

How to Get Sermorelin Prescribed: Four Steps
Getting a sermorelin prescription starts with a compound-specific medical intake, followed by a real clinician's review. Symptoms and labs can inform the decision, but neither guarantees a prescription.
-

How to Choose a Tirzepatide Provider: 7 Checks
Most of the difference between a careful service and a careless one shows up before a vial ever arrives — in who reads your history, who makes the medicine, and whether anyone answers afterwards.
-

What Is Semaglutide Used For? A Plain Guide
Semaglutide has different jobs depending on the brand: blood sugar control, heart or kidney risk reduction, long-term weight management, or certain liver disease. Here is the plain list before a first visit.
-

503A Bulks List: What It Means
The 503A bulks list is a narrow ingredient pathway for patient-specific compounding. Here is how it differs from FDA categories, drug review and the separate 503B list.
-

Is BPC-157 FDA Approved? No—The Vote Was Advisory
BPC-157 is not FDA-approved, and no approved BPC-157 product exists anywhere. The July 2026 vote was advice on compounding, not drug approval.
-

Paradigm Peptides: A Lab Certificate Is Not Proof
The Paradigm Peptides sentencing exposed a simple weakness in buying medicine from an unlicensed website: a polished lab certificate can be fake. The safer difference is an accountable chain—a prescriber, a named pharmacy and records regulators can inspect.
-

How to Report Peptide Side Effects So It Counts
An NBC News investigation in August found that problems linked to peptides often go nowhere at all. Here is where a report actually lands, and in what order to make it.
-

Kisspeptin Benefits: What Human Studies Found
In people, kisspeptin has done two things reliably: switched on the reproductive hormone system, and changed how the brain handles sexual cues. Nearly all of it was measured over hours, in a hospital.
-

Sermorelin Cost: What You’re Really Paying For
In three current public telehealth listings, recurring sermorelin plans run from $149 to $279 a month. The useful comparison is not just the vial price, but what the plan includes and who is accountable for it.
-

Is Sermorelin FDA Approved? Not Since 2009
Geref, the only sermorelin product the United States ever approved, left the market in 2008 and its approvals were withdrawn in 2009 — not over safety. Here is what that means for a prescription today.
-

Compounded Tirzepatide Court Ruling Upholds FDA
The Fifth Circuit left FDA's tirzepatide shortage decision in place. That closes the broad shortage-era compounding route, but it does not erase the narrower rules for an identified patient.
-

Kisspeptin Side Effects: What Human Trials Found
Short human trials suggest few systemic effects, while injection-site stinging can happen and repeated exposure can blunt the hormone response. The major unknown is long-term safety.
-

Does Tesamorelin Work? What the Trials Show
Tesamorelin reduced visceral abdominal fat in two large phase 3 trials, but those studies involved adults with HIV-associated lipodystrophy. The evidence does not establish it as a general weight-loss medication or promise the same result for every patient.
-

LillyDirect Tirzepatide vs Compounded Tirzepatide
LillyDirect supplies branded Zepbound in fixed-strength single-dose vials. Compounded tirzepatide is prepared by a licensed pharmacy for an individual prescription, so it is a different finished product and a different fulfillment route.
-

PT-141 Benefits: What the Human Trials Show
The strongest evidence is specific: studies found higher desire scores and less distress about low desire in premenopausal women with HSDD. Earlier, smaller trials in men measured erectile response, not broad sexual performance.
-

Thymosin Alpha-1 Benefits: What Studies Show
Thymosin alpha-1 has a credible immune-modulating mechanism, but its human evidence is condition-specific and mixed. The strongest trials do not support a blanket promise of stronger immunity.
-

Does Semaglutide Expire? Pens, Vials, and BUDs
Yes, semaglutide expires, but the date depends on whether it is an Ozempic pen, a Wegovy single-dose pen, or a compounded vial. The printed expiration date or beyond-use date always wins.
-

Is Semaglutide the Same as Ozempic?
Ozempic is a Novo Nordisk product that contains semaglutide. Compounded semaglutide may name the same base molecule, but it is not Ozempic and the finished products are not interchangeable.
-

Is Tesamorelin FDA Approved? Not Every Form
Egrifta has an indication-specific approval for adults with HIV and lipodystrophy. Tesamorelin offered here is dispensed as a compounded medication, which is different from an FDA-approved product: the formulation is not FDA-approved.
-

Peptides With Semaglutide: What the Evidence Says
Evidence gaps depend on the specific peptide combined with semaglutide; [cagrilintide–semaglutide has randomized phase 3 trial data](https://pubmed.ncbi.nlm.nih.gov/40544433/), while the combinations discussed here do not. A provider has to judge each compound on its own evidence, risks, and purpose.
Page 2 of 4 · 73 articles